2024 annual financial data
Aquestive Therapeutics 2024 Operating margin
Direct answer
Operating margin was -53.46%.
Operating income was -30,771,000 USD and net income was -44,137,000 USD.
Operating cash flow was -35,759,000 USD.
Get free Aquestive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 57,561,000 USD
- Operating income
- -30,771,000 USD
- Net income
- -44,137,000 USD
- Operating cash flow
- -35,759,000 USD